FDA Okays Regeneron COVID-19 Antibody as Preventive for Chronic Lymphocytic Leukemia (CLL) and other Immunocompromised Patients
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
CLL Society’s Official Statement Concerning CLL (chronic lymphocytic leukemia) Patients Working and Traveling During the COVID-19 Pandemic (8/16/2020 update)
As the COVID-19 pandemic stretches on, we have updated our official statement concerning working and traveling for people with CLL that you can download for your own reference and to share with the appropriate people in your life including HR, co-workers, extended family and friends.
Official statement for reading and download.
Also the Job Accommodation Network has published this helpful blog post: THE ADA AND MANAGING REASONABLE ACCOMMODATION REQUESTS FROM EMPLOYEES WITH DISABILITIES IN RESPONSE TO COVID-19 in an effort to help best manage the special needs of vulnerable folks such as people living with CLL and other high risk conditions.
Related posts